共 50 条
- [41] Glucagon-like peptide-1 receptor agonists and risk of acute pancreatitis in patients with type 2 diabetes DIABETES OBESITY & METABOLISM, 2017, 19 (06): : 906 - 908
- [45] Effectiveness of glucagon-like peptide-1 agonists in type 2 diabetes DIABETOLOGIE, 2023, 19 (03): : 359 - 360
- [46] Determinants of the effectiveness of glucagon-like peptide-1 in type 2 diabetes JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2001, 86 (08): : 3853 - 3860
- [47] Therapeutics Glucagon-like peptide-1 analogues for type 2 diabetes BRITISH MEDICAL JOURNAL, 2011, 342 : 433 - 435
- [48] Glucagon-Like Peptide-1 Receptor Agonist (GLP-1RA) Therapy Adherence for Patients with Type 2 Diabetes in a Medicare Population Advances in Therapy, 2017, 34 : 658 - 673
- [50] Glucagon-like peptide-1 in type 2 diabetes:: the β-cell and beyond DIABETES OBESITY & METABOLISM, 2008, 10 : 2 - 13